2026 MIPS Improvement Activity IA_PSPA_22: CDC Training on CDC’s Guideline for Prescribing Opioids for Chronic Pain
Written by Tucker Deyett, Dedicated Advisor, ReportingMD. Source data: CMS Quality Payment Program 2026 measure specifications and benchmark files.
Subcategory: Patient Safety and Practice Assessment
At a glance
IA_PSPA_22, CDC Training on CDC’s Guideline for Prescribing Opioids for Chronic Pain, is a 2026 MIPS improvement activity in the Patient Safety and Practice Assessment subcategory, included in 1 MVP. For PY2026 activities are not weighted: clinicians with small practice, rural, non-patient-facing, or HPSA status attest to one activity, all other Traditional MIPS participants attest to two, and MVP participants attest to one.
Activity description
Completion of all the modules of the Centers for Disease Control and Prevention (CDC) course “Applying CDC’s Guideline for Prescribing Opioids” that reviews the 2016 “Guideline for Prescribing Opioids for Chronic Pain.” Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may change on a year by year basis but over 4 years there would be a reasonable expectation for the set of modules to have undergone substantive change, for the improvement activities performance category score.
Activity details
- Activity ID: IA_PSPA_22
- Subcategory: Patient Safety and Practice Assessment
- Programs: Traditional MIPS, APP, APP Plus
- First performance year: 2018
MVPs that include this activity
Podiatry
Need help with IA_PSPA_22?
ReportingMD is a CMS qualified registry and healthcare data pipe with a 100% submission rate since 2001. We confirm IA attestations and documentation with every client before submission. Talk to a ReportingMD advisor or browse the full 2026 MIPS directory.
